Page 31«..1020..30313233..4050..»

Category Archives: Biotechnology

The biotechnology trial of the century over CRISPR patent settled in US court – NEWS.com.au

Posted: Published on February 17th, 2017

CRISPR is a life-changing genetic modification technology that could potentially cure cancer and eradicate genetic conditions before a child is born. But there is a dark side to the potential of this technology. The patent dispute over CRISPR technology has been settled. AN INFLUENTIAL US science advisory committee this week said genetic modification of human embryos should be allowed in the future to eliminate diseases, sparking new debate on a controversial topic. The report by the National Academy of Sciences (NAS) caused concern among some researchers who fear that genetic tools could be used to boost certain peoples intelligence or create people with particular physical traits. Clinical trials for genome editing of the human germ line adding, removing or replacing DNA base pairs in gametes or early embryos could be permitted in the future, said the report, released Wednesday (AEST). But only, it added, for serious conditions under stringent oversight. The emergence of inexpensive and accurate gene-editing technology, known as CRISPR/Cas9, has fuelled an explosion of new research opportunities and potential clinical applications, both heritable and non-heritable, to address a wide range of human health issues, the report said. The committee of international experts was convened to examine scientific, ethical … Continue reading

Posted in Biotechnology | Comments Off on The biotechnology trial of the century over CRISPR patent settled in US court – NEWS.com.au

Hoa Lac park hoped to become IT, biotechnology start-up centre … – VietNamNet Bridge

Posted: Published on February 17th, 2017

The Government will issue a new decree on mechanisms for the Hoa Lac Hi-Tech Park, enabling it to play an extremely important role in enhancing the countrys science and technology capacity, Prime Minister Nguyen Xuan Phuc has said. Prime Minister Nguyen Xuan Phuc visits a production facility of Vietnam Post and Telecommunication Industry Technology JSC at Hoa Lac Hi-Tech Park The PM and other Government and ministry officials visited the park on February 16. Located in Thach That and Quoc Oai districts, Hanoi, on a land area of 1,586 hectares, the Hoa Lac Hi-Tech Park is expected to become a science city hosting investors in biotechnology, information communication, new material technology, and automation. Modern infrastructure is being built at the park using the State budget and the official development assistance (ODA) supported by the Japanese government. According to the parks management board, it has so far received 1,530 hectares of land out of the total 1,586 hectares. The park counts 78 valid investment projects, including nine foreign ones, with a total registered capital of over 60 trillion VND (2.68 million USD), in the spheres of high technology, training, trade and services, and social infrastructure. Thirty-six projects have been put into … Continue reading

Posted in Biotechnology | Comments Off on Hoa Lac park hoped to become IT, biotechnology start-up centre … – VietNamNet Bridge

Why Nigeria Needs To Key Into Biotechnology Global Evolution | – Leadership Newspapers

Posted: Published on February 14th, 2017

A report recently published by the United Nations Food and Agriculture Organisation (FAO) says a total of 8.1 million people are currently facing acute food insecurity in Nigeria. According to the report, the food crisis, which represents 9 percent of the population, may further deteriorate to 8.7 million in the next lean period of June-August 2017. It adds that the number of severely food-insecure people may rise to 11 million, as over 2 million people may likely fall into emergency situation, while another 121,000 is prone to famine. With the current population of over 180 million people, famine, malnutrition and hunger are staring the nation in the face. All these emergency situations are closely linked with the inability to produce enough food to feed the people, which make it obvious that the conventional method of agriculture is not working for us. Agricultural biotechnology has been suggested as one of the tools that can contribute to solving the food production deficit in the country and has taken concrete steps to entrench biotechnology in agricultural production. This is because Nigeria, like most African countries, may face two daunting challenges in the 21st century: how to feed its growing population and secondly how … Continue reading

Posted in Biotechnology | Comments Off on Why Nigeria Needs To Key Into Biotechnology Global Evolution | – Leadership Newspapers

White Biotechnology Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024 – Yahoo Finance

Posted: Published on February 14th, 2017

LONDON, Feb. 13, 2017 /PRNewswire/ -- This report on the white biotechnology market studies the current as well as future prospects of the market globally. Environment concerns related to emission of greenhouse gases and dependence on non-renewable resources are the major challenges in the developed and developing nations. This research report provides a detailed analysis of the white biotechnology market and helps understand the various driving factors for the growth of the market. The market overview section analyzes market dynamics and trends such as drivers, restraints, and opportunities that influence the current nature and future status of the market. Porter's Five Forces Analysis has been covered in terms of bargaining power of buyers and suppliers, threat of new entrants and substitutes, and competitive rivalry in the global white biotechnology market. Value chain analysis and other market dynamics factors such as market attractiveness analysis have also been explained in order to deliver a thorough analysis of the overall competitive scenario of the global casting and splinting (supplies and equipment) market. The white biotechnology market has been segmented based on product, application, feedstock, and region. Based on product, the market has been segmented into biochemical, biofuel, biomaterial, and bioproduct. In terms of … Continue reading

Posted in Biotechnology | Comments Off on White Biotechnology Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024 – Yahoo Finance

IBB: Merck Joins The Drug Pricing Coalition For Transparency – Seeking Alpha

Posted: Published on February 14th, 2017

Introduction Although the political uncertainty has abated, Donald Trump has been able to single handily influence the movement of specific stocks [i.e. Lockheed Martin (NYSE:LMT), Ford (NYSE:F), Boeing (NYSE:BA) and others] and sectors (i.e. automotive, biotechnology, defense and healthcare). The overall healthcare sector has become volatile on the heels of any statement or tweet from Donald Trump. Case in point, Trump recently held a press conference and stated his stance with regard to the pharmaceutical industry and more specifically drug pricing. Trump stated that drug companies are "getting away with murder" when speaking to the drug pricing issue that has taken the spotlight. These remarks immediately resulted in a broad sell-off across the entire biotech cohort. The iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) shed more than 2.5% or $7 per share as these comments were heard during the live broadcast. The healthcare sector has been faced with a political backdrop that's put the entire industry on edge. The overall healthcare umbrella has become sensitive to any tweet from President Trump as he vows to bring down drug prices. As he pursues his agenda against drug pricing, much of these threats may have already been priced-in as seen in many healthcare related … Continue reading

Posted in Biotechnology | Comments Off on IBB: Merck Joins The Drug Pricing Coalition For Transparency – Seeking Alpha

Amarantus Announces Passing of Biotechnology Legend Dr. Joseph Rubinfeld – Yahoo Finance

Posted: Published on February 12th, 2017

SAN FRANCISCO, February 10, 2017 /PRNewswire/ -- Amarantus BioScience Holdings, Inc. (AMBS), a biotechnology company focused on developing products for Regenerative Medicine, Neurology and Orphan Diseases, today, with great sadness, announced the death of biotechnology legend Dr. Joseph Rubinfeld, who was an independent director of the Company. Dr. Rubinfeld is survived by his wife, Loretta, and children Bonnie, Randee, Susan and Steven and their respective families. "Dr. Rubinfeld, a co-founder of Amgen Inc., represented the best of the biotechnology industry. He was pragmatic, brilliant, honest and caring and always focused on the needs of patients" said Dr. John Commissiong, Chief Scientific Officer at Amarantus. "Immediately prior to his passing, Dr. Joe was selflessly working very hard to help turn Amarantus around. We will honor his memory by accelerating that effort to the best of our abilities." Obituary of Dr. Joe Rubinfeld: http://www.oakmontmortuary.com/book-of-memories/2807770/Rubinfeld-Joseph/obituary.php Joseph Rubinfeld Resident of Danville, CA October 24, 1932 - December 26, 2016 Joseph "Dr. Joe" Rubinfeld, a resident of Danville, passed away unexpectedly on December 26, 2016, at his home at the age of 84. Joe was born on October 24, 1932 in Brooklyn, New York to Mechel and Mary Rubinfeld. He married his wife and soul … Continue reading

Posted in Biotechnology | Comments Off on Amarantus Announces Passing of Biotechnology Legend Dr. Joseph Rubinfeld – Yahoo Finance

Harry Boxer’s stocks to watch: biotechnology and technology … – MarketWatch

Posted: Published on February 11th, 2017

Biotechnology and technology stocks are dominating our charts to watch this week, because they are displaying strong technical momentum. Esperion Therapeutics Inc. ESPR, +3.55% is absolutely rocketing. The clinical-stage biopharma, which is focused on developing drugs that treat cardiovascular disease, popped 29% on Friday in response to good clinical news from Amgen AMGN, +0.25% regarding its own cardiovascular drug. The stock followed through on Monday and then again Tuesday, up $2.48, or 14%, to $20.14 on nearly 3.4 million shares traded. The stock pulled back toward the close, testing the bottom of its rising channel and resting in a tight wedge formation. This formation looks poised to break to the upside, with the next target at the channel top near $22. Exelixis Inc. EXEL, -1.87% also had a strong session on Tuesday, up 54 cents, or 2.7%, to $20.57, on nearly 6.7 million shares traded. The cancer-drug companys stock needs to get through the rising trendline, near $21, connecting the most recent tops from September, December and January. The challenge beyond that would be the mid-channel line at around $22.75, a break through that could accelerate the stock into the high $20s. Finisar Corp. FNSR, +5.46% edged above resistance on … Continue reading

Posted in Biotechnology | Comments Off on Harry Boxer’s stocks to watch: biotechnology and technology … – MarketWatch

Why Cellect Biotechnology Ltd Shares Skyrocketed Higher Today – Fox Business

Posted: Published on February 11th, 2017

What happened Cellect Biotechnology (NASDAQ: APOP) stock is up nearly 30% at 12:06 p.m. EST after the company announced that it treated the first patient in the biotech's phase 1/2 trial, dubbed ApoGraft01, testing its stem cell technology ApoGraft in patients with blood cancer. Treating the first patient shouldn't have come as much of a surprise to investors. In November, the company said the Israeli Ministry of Health had given its approval to begin the trial. Perhaps investors are just really happy that the trial is finally starting. Also keep in mind that Cellect Biotechnology has a fairly low market cap, so the relative increase in valuation wasn't that much. Image source: Getty Images. Cellect Biotechnology's ApoGraft attempts to better select stem cells to help prevent graft-versus-host disease (GvHD), which occurs in 25% to 50% of recipients of allogeneic stem cell transplantation. GvHD happens when the donated stem cells produce immune cells that start mistakenly attacking the patients' normal cells because they see it as foreign. GvHD leads to 15% of the deaths that occur after allogeneic stem cell transplantation. Continue Reading Below ADVERTISEMENT ApoGraft01 will enroll 12 patients, so it shouldn't take too long for Cellect Biotechnology to fully … Continue reading

Posted in Biotechnology | Comments Off on Why Cellect Biotechnology Ltd Shares Skyrocketed Higher Today – Fox Business

Revolutionizing Biotechnology with Artificial Restriction Enzymes … – Genetic Engineering & Biotechnology News (press release)

Posted: Published on February 11th, 2017

Scientists at the University of Illinois say they have developed a new technique of genetic engineering for basic and applied biological research and medicine. Their work ("Programmable DNA-Guided Artificial Restriction Enzymes"), reported inACS Synthetic Biology,could open new doors in genomic research by improving the precision and adherence of sliced DNA, according to the investigators. "Using our technology, we can create highly active artificial restriction enzymes with virtually any sequence specificity and defined sticky ends of varying length," said Huimin Zhao, Ph.,D., professor of chemical and biomolecular engineering, who leads a synthetic biology research group at the Carl R. Woese Institute for Genomic Biology at Illinois. "This is a rare example in biotechnology where a desired biological function or reagent can be readily and precisely designed in a rational manner." Restriction enzymes cut DNA at a specific site and create a space wherein foreign DNA can be introduced for gene-editing purposes. This process is not achieved only by naturally occurring restriction enzymes; artificial restriction enzymes, or AREs, have risen to prominence in recent years. CRISPR/Cas9, a bacterial immune system used for "cut-and-paste" gene editing, and TALENs, or transcription activator-like effector nucleases, which are modified restriction enzymes, are two popular examples of … Continue reading

Posted in Biotechnology | Comments Off on Revolutionizing Biotechnology with Artificial Restriction Enzymes … – Genetic Engineering & Biotechnology News (press release)

Why Bioethics Matters in Biotechnology – Azusa Pacific University

Posted: Published on February 11th, 2017

The last five years have witnessed amazing acceleration of innovation in biotechnology. CRISPR will lead to precision gene editing that could vastly improve food crop yields and provide cures to cancer. Lightning-fast gene sequencing will enable early detection of cancer from a simple blood test. High-speed bulk data transfer allows the entire genomes of millions of people to be compared online in the search for cures to both common and rare diseases. Neuromorphic chips will accelerate the dawn of artificial intelligence, and smart prostheses will allow para- and quadriplegic patients to move, the deaf to hear, and the blind to see. Discovery of synergies in applications that blur the boundaries of traditional science, technology, engineering, and mathematics will continue to fuel this exponential growth of innovation. In spite of this exuberant trend, it is important to remember that innovation and discovery often outpace the regulatory structures that ensure their best and most ethical use in society. The bioethics field traditionally is interpreted as pertaining mainly to the medical interests of humans. It has dealt with five key issues: beneficence, non-maleficence, patient autonomy, social justice, and patient confidentiality. However, with the advent of nanotechnology and other technologies that allow inter-kingdom transfer … Continue reading

Posted in Biotechnology | Comments Off on Why Bioethics Matters in Biotechnology – Azusa Pacific University

Page 31«..1020..30313233..4050..»